Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes,Source_Sheet,Source_DB
Glycolysis and Gluconeogenesis WP534,4/45,1.1156847337006046E-10,1.7850955739209673E-9,0,0,1946.7317073170732,44612.048629442274,G6PC;PC;PCK1;FBP1,Gluconeogenesis,wikipathways
Angiopoietin Like Protein 8 Regulatory Pathway WP3915,3/132,2.7830287070272985E-6,2.2264229656218388E-5,0,0,231,2954.9452456376971,G6PC;PCK1;FBP1,Gluconeogenesis,wikipathways
TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,2/16,5.9914892032562716E-6,3.1954609084033446E-5,0,0,951.47619047619048,11441.663476001768,PC;PCK1,Gluconeogenesis,wikipathways
Amino Acid metabolism WP3925,2/91,2.0293664218794575E-4,8.1174656875178299E-4,0,0,149.10861423220973,1267.8133987163728,PC;PCK1,Gluconeogenesis,wikipathways
Biotin Metabolism (including IEMs) WP5031,1/9,2.24816055240216E-3,6.4921017501795662E-3,0,0,624.59375,3808.5496634307242,PC,Gluconeogenesis,wikipathways
PI3K-Akt signaling pathway WP4172,2/340,2.7854127237562309E-3,6.4921017501795662E-3,0,0,38.77120315581854,228.10491560915835,G6PC;PCK1,Gluconeogenesis,wikipathways
Alanine and aspartate metabolism WP106,1/12,2.9966530298936489E-3,6.4921017501795662E-3,0,0,454.18181818181819,2638.9141192765878,PC,Gluconeogenesis,wikipathways
Estrogen Receptor Pathway WP2881,1/13,3.2460508750897831E-3,6.4921017501795662E-3,0,0,416.3125,2385.6022367218384,PCK1,Gluconeogenesis,wikipathways
Fatty Acid Biosynthesis WP357,1/22,5.4883894433205137E-3,9.757136788125358E-3,0,0,237.78571428571428,1237.7032790036255,PC,Gluconeogenesis,wikipathways
PPAR signaling pathway WP3942,1/67,1.6639666196472655E-2,2.6623465914356249E-2,0,0,75.48863636363636,309.19888069233861,PCK1,Gluconeogenesis,wikipathways
Thyroid hormones production and their peripheral downstream signaling effects WP4746,1/95,2.352761014601E-2,3.4221978394196363E-2,0,0,52.928191489361701,198.45852252396736,PFKFB2,Gluconeogenesis,wikipathways
DNA damage response (only ATM dependent) WP710,1/110,2.7201672447497008E-2,3.6268896596662673E-2,0,0,45.610091743119263,164.4005184703249,G6PC,Gluconeogenesis,wikipathways
Adipogenesis WP236,1/130,3.2083212007385425E-2,3.9487030162935907E-2,0,0,38.5,132.41776147898338,PCK1,Gluconeogenesis,wikipathways
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,1/158,3.8884427657500428E-2,4.4439345894286199E-2,0,0,31.589171974522294,102.57514070844167,G6PC,Gluconeogenesis,wikipathways
Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,1/303,7.3496134453805137E-2,7.7253425371848594E-2,0,0,16.302152317880793,42.557134879952422,PFKFB2,Gluconeogenesis,wikipathways
Nuclear Receptors Meta-Pathway WP2882,1/319,7.7253425371848594E-2,7.7253425371848594E-2,0,0,15.46933962264151,39.611781428237286,PCK1,Gluconeogenesis,wikipathways
Glycolysis and Gluconeogenesis WP534,14/45,6.020130343884059E-36,1.2642273722156525E-34,0,0,3003.5268817204301,243579.88620374174,TPI1;PKLR;ENO1;ENO2;HK2;HK1;PFKL;PKM;PGK1;PGK2;ALDOB;ALDOA;PFKM;GAPDH,Gluconeogenesis,wikipathways
Pathways in clear cell renal cell carcinoma WP4018,15/85,9.719417401140831E-35,1.0205388271197872E-33,0,0,2133.5357142857142,167090.73523406373,TPI1;PKLR;ENO1;ENO2;HK2;HK1;PFKL;PKM;PGK1;PGK2;ALDOB;ALDOA;PFKM;GAPDH;PGM1,Gluconeogenesis,wikipathways
Computational Model of Aerobic Glycolysis WP4629,8/12,1.8924156290373332E-23,1.3246909403261334E-22,0,0,4439.7777777777774,232296.29036494112,PKM;TPI1;PGK1;ENO1;ALDOA;PFKM;GAPDH;HK1,Gluconeogenesis,wikipathways
Cori Cycle WP1946,6/17,1.7145322757072292E-15,9.0012944474629539E-15,0,0,990.34710743801656,33671.441242826244,TPI1;PGK1;PGK2;ALDOA;GAPDH;HK1,Gluconeogenesis,wikipathways
Glycolysis in senescence WP5049,5/11,1.068937434660467E-13,4.4895372255739619E-13,0,0,1387.2916666666667,41434.158504582083,PKM;PGK1;ENO1;GAPDH;HK1,Gluconeogenesis,wikipathways
Metabolic reprogramming in colon cancer WP4290,6/42,7.1833669877793269E-13,2.5141784457227646E-12,0,0,302.22727272727275,8450.8300379663306,PFKL;PKM;PGK1;ENO1;ALDOB;GAPDH,Gluconeogenesis,wikipathways
Photodynamic therapy-induced HIF-1 survival signaling WP3614,4/37,2.3180132928269954E-8,6.9540398784809868E-8,0,0,186.01398601398603,3270.120342895983,PFKL;PKM;PGK1;HK1,Gluconeogenesis,wikipathways
Glycogen Synthesis and Degradation WP500,3/40,4.9422046760553853E-6,1.2973287274645386E-5,0,0,115.51737451737452,1411.3565152386329,HK2;PGM1;HK1,Gluconeogenesis,wikipathways
HIF1A and PPARG regulation of glycolysis WP2456,2/8,1.8982825688105916E-5,4.4293259938913809E-5,0,0,443.93333333333334,4826.4325006402914,TPI1;GAPDH,Gluconeogenesis,wikipathways
Glucuronidation WP698,2/26,2.1836712816906202E-4,4.5857096915503026E-4,0,0,110.88333333333334,934.67252279457887,PGM1;HK1,Gluconeogenesis,wikipathways
7q11.23 copy number variation syndrome WP4932,2/104,3.4612740273215416E-3,6.607886779432034E-3,0,0,25.988235294117647,147.2524218660231,PKLR;GAPDH,Gluconeogenesis,wikipathways
VEGFA-VEGFR2 Signaling Pathway WP3888,3/432,5.43215897388324E-3,9.5062782042956706E-3,0,0,9.7672327672327679,50.940207669159264,PGK1;ALDOA;GAPDH,Gluconeogenesis,wikipathways
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,2/158,7.8024856073765532E-3,1.1990905572624968E-2,0,0,16.946153846153845,82.244987548836988,ALDOA;GAPDH,Gluconeogenesis,wikipathways
Insulin Signaling WP481,2/160,7.9939370484166453E-3,1.1990905572624968E-2,0,0,16.729957805907173,80.790169021253391,PFKL;PFKM,Gluconeogenesis,wikipathways
Fatty acid beta-oxidation WP143,1/34,2.8521354338754766E-2,3.992989607425667E-2,0,0,37.784090909090907,134.40187279306201,TPI1,Gluconeogenesis,wikipathways
16p11.2 proximal deletion syndrome WP4949,1/74,6.1095625316414638E-2,8.0188008227794219E-2,0,0,17.046232876712327,47.649590694413071,ALDOA,Gluconeogenesis,wikipathways
Alzheimer's disease WP2059,1/83,6.8281787330545546E-2,8.4348090231850387E-2,0,0,15.168445121951219,40.713808681356575,GAPDH,Gluconeogenesis,wikipathways
Amino Acid metabolism WP3925,1/91,7.4625999348843328E-2,8.7063665906983889E-2,0,0,13.814583333333333,35.852522791117856,PKM,Gluconeogenesis,wikipathways
Ectoderm Differentiation WP2858,1/138,0.11108481371066996,0.12277795199600365,0,0,9.0538321167883211,19.895445529940535,PGM1,Gluconeogenesis,wikipathways
Nonalcoholic fatty liver disease WP4396,1/155,0.12393582001851285,0.13013261101943849,0,0,8.0474837662337659,16.803077119770684,PKLR,Gluconeogenesis,wikipathways
IL-18 signaling pathway WP4754,1/272,0.20775122366844603,0.20775122366844603,0,0,4.5461254612546123,7.1438449917377955,ENO1,Gluconeogenesis,wikipathways
Photodynamic therapy-induced HIF-1 survival signaling WP3614,4/37,1.2401553647179135E-9,2.5139762535348211E-8,0,0,483.83030303030301,9922.4059683837877,LDHA;SLC16A1;SLC2A1;SLC2A3,Gluconeogenesis,wikipathways
Metabolic reprogramming in colon cancer WP4290,4/42,2.0996752377108788E-9,2.5139762535348211E-8,0,0,420.06315789473683,8393.4849126215595,LDHA;SLC2A1;SLC16A3;GLS,Gluconeogenesis,wikipathways
Glycolysis and Gluconeogenesis WP534,4/45,2.7933069483720234E-9,2.5139762535348211E-8,0,0,389.26829268292681,7667.0437298393008,LDHB;LDHA;SLC2A1;SLC2A3,Gluconeogenesis,wikipathways
Ketogenesis and Ketolysis WP4742,2/8,5.0328413188770481E-6,2.717734312193606E-5,0,0,951.66666666666663,11609.882108963659,SLC16A1;SLC2A1,Gluconeogenesis,wikipathways
HIF1A and PPARG regulation of glycolysis WP2456,2/8,5.0328413188770481E-6,2.717734312193606E-5,0,0,951.66666666666663,11609.882108963659,LDHA;SLC2A1,Gluconeogenesis,wikipathways
Pathways in clear cell renal cell carcinoma WP4018,3/85,6.109106988779887E-6,2.7490981449509492E-5,0,0,121.39634146341463,1457.4516926667498,LDHB;LDHA;SLC2A1,Gluconeogenesis,wikipathways
Amino Acid metabolism WP3925,3/91,7.503927853888881E-6,2.8943721722142828E-5,0,0,113.08522727272727,1334.4151765285446,LDHA;GLUL;GLS,Gluconeogenesis,wikipathways
Computational Model of Aerobic Glycolysis WP4629,2/12,1.1852169299324696E-5,4.0001071385220847E-5,0,0,570.88571428571424,6475.556453852173,LDHA;SLC2A1,Gluconeogenesis,wikipathways
Cori Cycle WP1946,2/17,2.4394349832130377E-5,7.3183049496391137E-5,0,0,380.49523809523811,4041.3004289208102,LDHA;SLC2A1,Gluconeogenesis,wikipathways
Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,2/20,3.4056598001324132E-5,9.1952814603575163E-5,0,0,317.03174603174602,3261.459893047559,LDHA;SLC2A1,Gluconeogenesis,wikipathways
PI3K/AKT/mTOR - VitD3 signaling WP4141,2/22,4.1386405906523752E-5,1.0158481449783103E-4,0,0,285.3,2879.4068233054322,LDHA;SLC2A3,Gluconeogenesis,wikipathways
NRF2 pathway WP2884,2/146,1.8423520433626748E-3,4.1452920975660178E-3,0,0,39.378968253968253,247.9580313732076,SLC2A1;SLC2A3,Gluconeogenesis,wikipathways
Glycolysis in senescence WP5049,1/11,4.9400429229450454E-3,1.0260089147655095E-2,0,0,249.76249999999999,1326.3340991921912,LDHA,Gluconeogenesis,wikipathways
Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,2/303,7.6765042962079833E-3,1.4804686856972539E-2,0,0,18.690080683436165,91.013048782678965,SLC2A1;SLC2A3,Gluconeogenesis,wikipathways
Nuclear Receptors Meta-Pathway WP2882,2/319,8.4782519857504752E-3,1.5260853574350856E-2,0,0,17.732311852185671,84.587578064722337,SLC2A1;SLC2A3,Gluconeogenesis,wikipathways
Urea cycle and associated pathways WP4595,1/24,1.0750337464808102E-2,1.7074065385283454E-2,0,0,108.52173913043478,491.90930693624915,LDHB,Gluconeogenesis,wikipathways
"NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046",1/24,1.0750337464808102E-2,1.7074065385283454E-2,0,0,108.52173913043478,491.90930693624915,SLC2A1,Gluconeogenesis,wikipathways
Type 2 papillary renal cell carcinoma WP4241,1/34,1.519926045554118E-2,2.279889068331177E-2,0,0,75.598484848484844,316.49369990079617,SLC2A1,Gluconeogenesis,wikipathways
Synaptic Vesicle Pathway WP2267,1/51,2.2721633844606352E-2,3.2288637568651128E-2,0,0,49.852499999999999,188.6636842051162,SLC1A3,Gluconeogenesis,wikipathways
Proximal tubule transport WP4917,1/57,2.5364370254955197E-2,3.4241899844189516E-2,0,0,44.497767857142854,163.5030358762894,SLC2A1,Gluconeogenesis,wikipathways
p53 transcriptional gene network WP4963,1/67,2.9754818181739934E-2,3.8256194805094207E-2,0,0,37.736742424242422,132.63575146396252,SLC2A1,Gluconeogenesis,wikipathways
TNF-alpha signaling pathway WP231,1/92,4.0654126315732002E-2,4.9893700478398369E-2,0,0,27.335164835164836,87.545100688435838,GLUL,Gluconeogenesis,wikipathways
Fragile X Syndrome  WP4549,1/121,5.3160876149181691E-2,6.2406245914256774E-2,0,0,20.698958333333334,60.739697372377059,SLC16A1,Gluconeogenesis,wikipathways
Angiopoietin Like Protein 8 Regulatory Pathway WP3915,1/132,5.7866768719600295E-2,6.510011480955033E-2,0,0,18.950381679389313,54.00123507299854,SLC2A1,Gluconeogenesis,wikipathways
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,1/158,6.8907244430395656E-2,7.2434487543992676E-2,0,0,15.79140127388535,42.241903064880837,SLC1A3,Gluconeogenesis,wikipathways
Insulin Signaling WP481,1/160,6.9751728746067013E-2,7.2434487543992676E-2,0,0,15.591194968553459,41.516437796837891,SLC2A1,Gluconeogenesis,wikipathways
VEGFA-VEGFR2 Signaling Pathway WP3888,1/432,0.17845578098325815,0.17845578098325815,0,0,5.6728538283062644,9.77667816987646,LDHA,Gluconeogenesis,wikipathways
"GPCRs, Class C Metabotropic glutamate, pheromone WP501",8/15,1.5751784375170337E-20,4.8830531563028042E-19,0,0,1267.7460317460318,57805.838349731246,GRM3;GRM2;GRM5;GRM4;GRM7;GRM6;GRM8;GRM1,Gluconeogenesis,wikipathways
Common Pathways Underlying Drug Addiction WP2636,8/42,2.8284227556556856E-16,4.3840552712663124E-15,0,0,260.65359477124184,9331.8267542450867,GRIA1;GRIA2;GRM5;GRIN2A;GRIA3;GRM1;GRIN1;GRIA4,Gluconeogenesis,wikipathways
Synaptic signaling pathways associated with autism spectrum disorder WP4539,8/50,1.2783914223732442E-15,1.3210044697856859E-14,0,0,210.92063492063491,7233.1379931454367,GRIN3B;GRIN2A;GRIN3A;GRIN2C;GRIN2B;GRM1;GRIN2D;GRIN1,Gluconeogenesis,wikipathways
Disruption of postsynaptic signaling by CNV WP4875,6/33,2.8041563872999798E-12,2.1732212001574845E-11,0,0,221.63333333333333,5895.4285759300392,GRIN2A;GRIN2C;GRIN2B;GRM1;GRIN2D;GRIN1,Gluconeogenesis,wikipathways
Vitamin D-sensitive calcium signaling in depression WP4698,6/41,1.13064944477534E-11,7.0100265576071081E-11,0,0,170.90571428571428,4307.7885620137758,GRM5;GRIN2A;GRIN2C;GRIN2B;GRIN2D;GRIN1,Gluconeogenesis,wikipathways
Phosphodiesterases in neuronal function WP4222,6/53,5.7138619479437547E-11,2.8349341802037167E-10,0,0,127.19361702127659,2999.9302538967586,GRIA1;GRIN2A;GRIN2C;GRIN2B;GRIN2D;GRIN1,Gluconeogenesis,wikipathways
PKC-gamma calcium signaling pathway in ataxia WP4760,5/22,6.4014642778793595E-11,2.8349341802037167E-10,0,0,279.50980392156862,6560.6287564142895,GRIA1;GRIA2;GRM1;GRIA3;GRIA4,Gluconeogenesis,wikipathways
Fragile X Syndrome  WP4549,7/121,1.4883718528670387E-10,5.767440929859775E-10,0,0,64.18282548476455,1452.3397657188127,GRIA1;GRIA2;GRM5;GRIN2A;GRIN2B;GRM1;GRIN1,Gluconeogenesis,wikipathways
NO/cGMP/PKG mediated Neuroprotection WP4008,5/47,3.6483350044331255E-9,1.2566487237491878E-8,0,0,112.99319727891157,2195.3442578016629,GRIN2A;GRIN2C;GRIN2B;GRIN2D;GRIN1,Gluconeogenesis,wikipathways
MECP2 and Associated Rett Syndrome WP3584,5/72,3.255764346761215E-8,1.0092869474959767E-7,0,0,70.742714996446338,1219.6223520911738,GRIA1;GRID1;GRIA3;GRIN1;GRIA4,Gluconeogenesis,wikipathways
Alzheimer's disease WP2059,5/83,6.6913976952166351E-8,1.8857575322883245E-7,0,0,60.73260073260073,1003.2939381651508,GRIN2A;GRIN2C;GRIN2B;GRIN2D;GRIN1,Gluconeogenesis,wikipathways
Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,5/144,1.0508329221773858E-6,2.7146517156249133E-6,0,0,33.975676601575884,467.70669912941042,GRIA1;GRIA2;GRIN2B;GRIA3;GRIN1,Gluconeogenesis,wikipathways
MTHFR deficiency WP4288,3/25,4.4010050050353324E-6,1.0494704242776562E-5,0,0,118.29249011857708,1458.9814395139299,GRIN2A;GRIN2D;GRIN1,Gluconeogenesis,wikipathways
Splicing factor NOVA regulated synaptic proteins WP4148,3/42,2.1647377956110441E-5,4.7933479759958835E-5,0,0,66.672240802675589,716.10161780621377,GRIK2;GRIN2B;GRIN1,Gluconeogenesis,wikipathways
Ras signaling WP4223,3/184,1.7043384996781521E-3,3.4233391386729426E-3,0,0,14.263511890463608,90.923872241332589,GRIN2A;GRIN2B;GRIN1,Gluconeogenesis,wikipathways
Rett syndrome causing genes WP4312,2/48,1.7668847167344221E-3,3.4233391386729426E-3,0,0,36.10144927536232,228.83038390410115,GRIN2A;GRIN2B,Gluconeogenesis,wikipathways
Melanoma WP4685,2/68,3.5117758263918473E-3,6.4038265069498394E-3,0,0,25.136363636363637,142.06151318674151,GRM3;GRIN2A,Gluconeogenesis,wikipathways
"GPCRs, Other WP117",2/91,6.1982979638680012E-3,1.0674846493328225E-2,0,0,18.618913857677903,94.648886393878342,GRM8;GRM1,Gluconeogenesis,wikipathways
Serotonin and anxiety-related events WP3944,1/13,1.6773661823445914E-2,2.7367553501411755E-2,0,0,66.540000000000006,272.01188501169923,GRIN2D,Gluconeogenesis,wikipathways
ERK Pathway in Huntington's Disease WP3853,1/15,1.9330101754838777E-2,2.9961657720000104E-2,0,0,57.028571428571432,225.03997361391211,GRM1,Gluconeogenesis,wikipathways
Serotonin and anxiety WP3947,1/17,2.188015065344143E-2,3.2299270012223068E-2,0,0,49.895000000000003,190.70744238188936,GRM1,Gluconeogenesis,wikipathways
15q13.3 copy number variation syndrome WP4942,1/19,2.442382371261493E-2,3.4415387958684679E-2,0,0,44.346666666666664,164.6235293172426,GRM6,Gluconeogenesis,wikipathways
Purine metabolism and related disorders WP4224,1/22,2.8227411859507716E-2,3.8045642071510399E-2,0,0,38.005714285714284,135.5839309094672,GRM5,Gluconeogenesis,wikipathways
BDNF-TrkB Signaling WP3676,1/34,4.3299673200093314E-2,5.5507262602489178E-2,0,0,24.170909090909092,75.887232515870664,GRIN1,Gluconeogenesis,wikipathways
Sleep regulation WP3591,1/38,4.8273621231532039E-2,5.5507262602489178E-2,0,0,21.553513513513515,65.325897756806043,GRIN2A,Gluconeogenesis,wikipathways
Amyotrophic lateral sclerosis (ALS) WP2447,1/38,4.8273621231532039E-2,5.5507262602489178E-2,0,0,21.553513513513515,65.325897756806043,GRIA1,Gluconeogenesis,wikipathways
IL-18 signaling pathway WP4754,2/272,4.8345035169909928E-2,5.5507262602489178E-2,0,0,6.0814814814814815,18.423189812994789,GRM7;GRIN2B,Gluconeogenesis,wikipathways
3q29 copy number variation syndrome WP4906,1/63,7.8802053875780986E-2,8.7245131076757521E-2,0,0,12.846451612903225,32.64047260238857,GRIA1,Gluconeogenesis,wikipathways
Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,1/66,8.2401554194611037E-2,8.8084420001135935E-2,0,0,12.251692307692307,30.582073768584642,GRIA1,Gluconeogenesis,wikipathways
Spinal Cord Injury WP2431,1/118,0.14268546642654423,0.1474416486407624,0,0,6.7887179487179488,13.21839830149686,GRIN1,Gluconeogenesis,wikipathways
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,1/158,0.18644734444168432,0.18644734444168432,0,0,5.0489171974522291,8.480193714632895,GRIN1,Gluconeogenesis,wikipathways
Pentose Phosphate Metabolism WP134,6/7,6.6123012864214628E-21,1.6530753216053657E-19,0,0,39980,1857684.9011896488,RPIA;G6PD;RPE;TALDO1;PGD;TKT,Gluconeogenesis,wikipathways
Metabolic reprogramming in colon cancer WP4290,5/42,3.9953554761101562E-12,4.9941943451376952E-11,0,0,674.12162162162167,17692.920957247978,RPIA;G6PD;TALDO1;TKT;PGD,Gluconeogenesis,wikipathways
Glutathione metabolism WP100,3/23,1.110748578776731E-7,9.2562381564727586E-7,0,0,499.27499999999998,7994.921264256981,G6PD;GPX1;GSR,Gluconeogenesis,wikipathways
Sulfation Biotransformation Reaction WP692,2/17,2.4394349832130377E-5,1.2197174916065188E-4,0,0,380.49523809523811,4041.3004289208102,G6PD;GSR,Gluconeogenesis,wikipathways
Cori Cycle WP1946,2/17,2.4394349832130377E-5,1.2197174916065188E-4,0,0,380.49523809523811,4041.3004289208102,G6PD;TALDO1,Gluconeogenesis,wikipathways
NRF2 pathway WP2884,3/146,3.099654486683811E-5,1.2915227027849213E-4,0,0,69.3986013986014,720.47093643361484,G6PD;GSR;PGD,Gluconeogenesis,wikipathways
Oxidative Stress WP408,2/33,9.4355619188798664E-5,3.3698435424570951E-4,0,0,183.963133640553,1705.0512168868192,GPX1;GSR,Gluconeogenesis,wikipathways
Vitamin D-sensitive calcium signaling in depression WP4698,2/41,1.4626426509152532E-4,4.5707582841101663E-4,0,0,146.16849816849816,1290.6818034038872,G6PD;GSR,Gluconeogenesis,wikipathways
One-carbon metabolism and related pathways WP3940,2/52,2.3591429006626741E-4,6.5531747240629831E-4,0,0,113.94857142857143,951.70325402274523,GPX1;GSR,Gluconeogenesis,wikipathways
Nuclear Receptors Meta-Pathway WP2882,3/319,3.1441969678247501E-4,7.8604924195618754E-4,0,0,31.13132911392405,251.06737802216946,G6PD;GSR;PGD,Gluconeogenesis,wikipathways
Selenium Micronutrient Network WP15,2/89,6.9072394340393231E-4,1.5698271440998462E-3,0,0,65.366174055829234,475.72000128280672,GPX1;GSR,Gluconeogenesis,wikipathways
VEGFA-VEGFR2 Signaling Pathway WP3888,3/432,7.6298796329304973E-4,1.5895582568605203E-3,0,0,22.799533799533801,163.66117078052136,GPX1;TKT;PGD,Gluconeogenesis,wikipathways
Thiamine metabolic pathways WP4297,1/9,4.0434660343014565E-3,7.7758962198104936E-3,0,0,312.234375,1720.6153032705638,TKT,Gluconeogenesis,wikipathways
Glycolysis in senescence WP5049,1/11,4.9400429229450454E-3,8.8215052195447247E-3,0,0,249.76249999999999,1326.3340991921912,G6PD,Gluconeogenesis,wikipathways
"NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046",1/24,1.0750337464808102E-2,1.7917229108013504E-2,0,0,108.52173913043478,491.90930693624915,G6PD,Gluconeogenesis,wikipathways
Amyotrophic lateral sclerosis (ALS) WP2447,1/38,1.6973844995694702E-2,2.6521632805772972E-2,0,0,67.412162162162161,274.77747713172664,GPX1,Gluconeogenesis,wikipathways
ATM Signaling Network in Development and Disease  WP3878,1/45,2.0072530463390581E-2,2.9518427152044974E-2,0,0,56.667613636363633,221.47987353276542,G6PD,Gluconeogenesis,wikipathways
TYROBP causal network in microglia WP3945,1/61,2.7122663879516524E-2,3.6465232479136078E-2,0,0,41.522916666666667,149.78917144936761,GPX1,Gluconeogenesis,wikipathways
Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,1/66,2.9316565848365818E-2,3.6465232479136078E-2,0,0,38.319230769230771,135.25165407819361,GPX1,Gluconeogenesis,wikipathways
p53 transcriptional gene network WP4963,1/67,2.9754818181739934E-2,3.6465232479136078E-2,0,0,37.736742424242422,132.63575146396252,GPX1,Gluconeogenesis,wikipathways
Folate Metabolism WP176,1/69,3.0630795282474307E-2,3.6465232479136078E-2,0,0,36.623161764705884,127.65916393890298,GPX1,Gluconeogenesis,wikipathways
Amino Acid metabolism WP3925,1/91,4.0220252479191559E-2,4.5704832362717683E-2,0,0,27.640277777777779,88.818843426343989,GSR,Gluconeogenesis,wikipathways
Male infertility WP4673,1/146,6.3826012989552219E-2,6.937610107560023E-2,0,0,17.108620689655172,47.075985644775116,GPX1,Gluconeogenesis,wikipathways
Vitamin D Receptor Pathway WP2877,1/182,7.8996223307942537E-2,7.941448038936727E-2,0,0,13.680939226519337,34.72708369011773,G6PD,Gluconeogenesis,wikipathways
Metapathway biotransformation Phase I and II WP702,1/183,7.941448038936727E-2,7.941448038936727E-2,0,0,13.605082417582418,34.462688086504492,GSR,Gluconeogenesis,wikipathways
TCA Cycle (aka Krebs or citric acid cycle) WP78,13/18,5.5748370485765719E-39,1.7281994850587374E-37,0,0,10388.040000000001,915005.11023931392,FH;MDH2;IDH2;SDHC;SDHA;SDHB;CS;SUCLA2;OGDH;SUCLG2;SUCLG1;ACO2;DLD,Gluconeogenesis,wikipathways
TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,11/16,2.7056167771152855E-32,4.1937060045286926E-31,0,0,6278.4857142857145,456366.75903496263,CS;FH;PDHA1;MDH1;IDH1;OGDH;SUCLG2;ACO1;DLAT;SDHA;DLD,Gluconeogenesis,wikipathways
Amino Acid metabolism WP3925,11/91,2.8653961180956066E-22,2.9609093220321268E-21,0,0,390.93214285714288,19391.862691719489,CS;FH;PDHA1;MDH1;MDH2;IDH1;OGDH;SUCLG1;ACO2;SDHA;DLD,Gluconeogenesis,wikipathways
Metabolic reprogramming in colon cancer WP4290,7/42,3.325768131563611E-15,2.5774703019617985E-14,0,0,362.67272727272729,12090.448174467574,FH;PDHA1;MDH2;IDH2;SUCLG2;ACO2;SDHB,Gluconeogenesis,wikipathways
Disorders of the Krebs cycle WP4236,4/7,1.6038105333121745E-11,9.9436253065354826E-11,0,0,1902.7619047619048,47295.151972418236,FH;SUCLA2;SUCLG2;SUCLG1,Gluconeogenesis,wikipathways
Glycolysis and Gluconeogenesis WP534,5/45,3.8423434562696263E-10,1.9852107857393068E-9,0,0,191.75,4157.0956049686365,PDHA1;MDH1;MDH2;DLAT;DLD,Gluconeogenesis,wikipathways
Mitochondrial CII Assembly WP4920,3/8,3.4176008683086065E-8,1.5135089559652402E-7,0,0,799.08,13737.577149046836,SDHC;SDHA;SDHB,Gluconeogenesis,wikipathways
TCA cycle in senescence WP5050,3/10,7.3152815006368097E-8,2.8346715814967638E-7,0,0,570.71428571428567,9377.2439048737961,FH;PDHA1;MDH1,Gluconeogenesis,wikipathways
Urea cycle and associated pathways WP4595,3/24,1.2242104658059254E-6,4.2167249377759651E-6,0,0,190.10476190476192,2587.9368897735044,FH;MDH1;MDH2,Gluconeogenesis,wikipathways
Fluoroacetic acid toxicity WP4966,2/6,1.1450402648511111E-5,3.549624821038445E-5,0,0,624.3125,7103.1065178402787,CS;ACO2,Gluconeogenesis,wikipathways
"Cerebral organic acidurias, including diseases WP4519",2/7,1.6022071431264729E-5,4.5153110397200604E-5,0,0,499.42500000000001,5514.4227735186505,MDH2;IDH2,Gluconeogenesis,wikipathways
Cytosine methylation WP3585,2/9,2.7437270887714988E-5,6.5427338270704967E-5,0,0,356.69642857142856,3746.5995382949022,IDH1;IDH2,Gluconeogenesis,wikipathways
Thiamine metabolic pathways WP4297,2/9,2.7437270887714988E-5,6.5427338270704967E-5,0,0,356.69642857142856,3746.5995382949022,PDHA1;OGDH,Gluconeogenesis,wikipathways
Electron Transport Chain (OXPHOS system in mitochondria) WP111,3/103,1.0232080283081646E-4,2.2656749198252216E-4,0,0,39.764000000000003,365.32767635514489,SDHC;SDHA;SDHB,Gluconeogenesis,wikipathways
"NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046",2/24,2.0868016842799032E-4,4.3127234808451338E-4,0,0,113.40909090909091,961.1089042220101,MDH1;MDH2,Gluconeogenesis,wikipathways
Nonalcoholic fatty liver disease WP4396,3/155,3.4201218417955051E-4,6.6264860684787908E-4,0,0,26.092105263157894,208.23233025316819,SDHC;SDHA;SDHB,Gluconeogenesis,wikipathways
7q11.23 copy number variation syndrome WP4932,2/104,3.8807726279611551E-3,7.0767030274585764E-3,0,0,24.362745098039216,135.25516392567505,OGDH;DLD,Gluconeogenesis,wikipathways
Acetylcholine Synthesis WP528,1/7,6.2838777740325952E-3,1.0822233944167248E-2,0,0,195.84313725490196,992.87927206115364,PDHA1,Gluconeogenesis,wikipathways
Iron metabolism in placenta WP2007,1/12,1.0749534506708167E-2,1.753871419515543E-2,0,0,106.79679144385027,484.09840988752489,ACO1,Gluconeogenesis,wikipathways
Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,1/20,1.7855195476470426E-2,2.767555298852916E-2,0,0,61.804953560371516,248.79341471282055,PDHA1,Gluconeogenesis,wikipathways
PI3K/AKT/mTOR - VitD3 signaling WP4141,1/22,1.9624065171284413E-2,2.889675068951951E-2,0,0,55.913165266106439,219.79457723601951,PDHA1,Gluconeogenesis,wikipathways
Glutathione metabolism WP100,1/23,2.0507371457078361E-2,2.889675068951951E-2,0,0,53.36898395721925,207.44368622737056,IDH1,Gluconeogenesis,wikipathways
Lipid Metabolism Pathway WP3965,1/29,2.5791446852810002E-2,3.4762384888570003E-2,0,0,41.920168067226889,153.33191684558912,PDHA1,Gluconeogenesis,wikipathways
Type 2 papillary renal cell carcinoma WP4241,1/34,3.0174267482518016E-2,3.7416091678322341E-2,0,0,35.559714795008915,124.48623298308226,FH,Gluconeogenesis,wikipathways
Fatty acid beta-oxidation WP143,1/34,3.0174267482518016E-2,3.7416091678322341E-2,0,0,35.559714795008915,124.48623298308226,DLD,Gluconeogenesis,wikipathways
Photodynamic therapy-induced HIF-1 survival signaling WP3614,1/37,3.2795014804391599E-2,3.8654829960872175E-2,0,0,32.591503267973856,111.38077026649427,PDHA1,Gluconeogenesis,wikipathways
Sleep regulation WP3591,1/38,3.3667109965920927E-2,3.8654829960872175E-2,0,0,31.70906200317965,107.5328454820737,DLAT,Gluconeogenesis,wikipathways
Tryptophan metabolism WP465,1/42,3.7148070085386981E-2,4.1128220451678445E-2,0,0,28.609756097560975,94.207448212762941,OGDH,Gluconeogenesis,wikipathways
Sterol regulatory element-binding proteins (SREBP) signaling WP1982,1/69,6.033663736484967E-2,6.4497784769322053E-2,0,0,17.226643598615915,48.3692416453001,MDH1,Gluconeogenesis,wikipathways
Pathways in clear cell renal cell carcinoma WP4018,1/85,7.3828067413955145E-2,7.6289002994420319E-2,0,0,13.934173669467787,36.312683743324982,MDH1,Gluconeogenesis,wikipathways
VEGFA-VEGFR2 Signaling Pathway WP3888,1/432,0.32512562237918019,0.32512562237918019,0,0,2.6683499385833218,2.9980076052940663,IDH2,Gluconeogenesis,wikipathways
Electron Transport Chain (OXPHOS system in mitochondria) WP111,2/103,1.4014910364866255E-3,9.8104372554063783E-3,0,0,43.757975797579761,287.49946574133952,UQCR10;SDHA,Gluconeogenesis,wikipathways
Nonalcoholic fatty liver disease WP4396,2/155,3.1349527155465568E-3,1.0248570257713745E-2,0,0,28.81045751633987,166.0963552659853,UQCR10;SDHA,Gluconeogenesis,wikipathways
Mitochondrial CII Assembly WP4920,1/8,4.3922443961630329E-3,1.0248570257713745E-2,0,0,285.45714285714286,1549.4370877511301,SDHA,Gluconeogenesis,wikipathways
TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,1/16,8.7669723009575276E-3,1.1500908573952579E-2,0,0,133.16,630.7474630602054,SDHA,Gluconeogenesis,wikipathways
Mitochondrial complex III assembly WP4921,1/16,8.7669723009575276E-3,1.1500908573952579E-2,0,0,133.16,630.7474630602054,UQCR10,Gluconeogenesis,wikipathways
TCA Cycle (aka Krebs or citric acid cycle) WP78,1/18,9.8579216348164949E-3,1.1500908573952579E-2,0,0,117.48235294117647,542.70737038143443,SDHA,Gluconeogenesis,wikipathways
Amino Acid metabolism WP3925,1/91,4.8938487444328285E-2,4.8938487444328285E-2,0,0,22.11,66.71009583505662,SDHA,Gluconeogenesis,wikipathways
Fatty Acid Biosynthesis WP357,3/22,6.4451106452766731E-8,1.7401798742247017E-6,0,0,630.72631578947369,10443.162003489322,FASN;ACACB;ACACA,Gluconeogenesis,wikipathways
Mitochondrial fatty acid synthesis pathway WP4317,2/5,1.3991087462114677E-6,1.8887968073854814E-5,0,0,2221,29938.358472423224,MCAT;ACACA,Gluconeogenesis,wikipathways
AMP-activated protein kinase (AMPK) signaling WP1403,3/69,2.1736023862629252E-6,1.9562421476366327E-5,0,0,181.14545454545456,2361.978167213847,FASN;ACACB;ACACA,Gluconeogenesis,wikipathways
Pathways in clear cell renal cell carcinoma WP4018,3/85,4.0852728151288471E-6,2.717734312193606E-5,0,0,145.6829268292683,1807.6515363015085,FASN;ACACB;ACACA,Gluconeogenesis,wikipathways
Biotin Metabolism (including IEMs) WP5031,2/9,5.0328413188770481E-6,2.717734312193606E-5,0,0,951.66666666666663,11609.882108963659,ACACB;ACACA,Gluconeogenesis,wikipathways
Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,2/20,2.6504300251431722E-5,1.1296952328791889E-4,0,0,369.88888888888891,3897.964407357134,ACACB;ACACA,Gluconeogenesis,wikipathways
FOXA2 pathway WP5066,2/21,2.9288394926497492E-5,1.1296952328791889E-4,0,0,350.40350877192981,3657.623672658719,FASN;ACACA,Gluconeogenesis,wikipathways
Lipid Metabolism Pathway WP3965,2/29,5.6534016206557991E-5,1.9080230469713323E-4,0,0,246.4814814814815,2410.7535494184467,FASN;ACACA,Gluconeogenesis,wikipathways
Sterol regulatory element-binding proteins (SREBP) signaling WP1982,2/69,3.240717098843516E-4,9.722151296530548E-4,0,0,99.129353233830841,796.45932271971026,FASN;ACACA,Gluconeogenesis,wikipathways
Leptin signaling pathway WP2034,2/76,3.9314244610752611E-4,1.0614846044903206E-3,0,0,89.72072072072072,703.53054643324492,ACACB;ACACA,Gluconeogenesis,wikipathways
7q11.23 copy number variation syndrome WP4932,2/104,7.347039673000961E-4,1.8033642833729631E-3,0,0,65,469.04278885498962,ACACB;ACACA,Gluconeogenesis,wikipathways
Leptin and adiponectin WP3934,1/10,3.9936462613403625E-3,8.2944960812453682E-3,0,0,317.1904761904762,1751.8590547314027,ACACA,Gluconeogenesis,wikipathways
Liver X receptor pathway WP2874,1/10,3.9936462613403625E-3,8.2944960812453682E-3,0,0,317.1904761904762,1751.8590547314027,FASN,Gluconeogenesis,wikipathways
IL-18 signaling pathway WP4754,2/272,4.8882840152581755E-3,9.4274048865693391E-3,0,0,24.348148148148148,129.55440124056366,PPT2;ACACB,Gluconeogenesis,wikipathways
Omega-9 FA synthesis WP4724,1/14,5.5872022837974E-3,1.005696411083532E-2,0,0,219.54945054945054,1138.8637280375192,FASN,Gluconeogenesis,wikipathways
SREBF and miR33 in cholesterol and lipid homeostasis WP2011,1/16,6.3831440708516521E-3,1.0771555619562162E-2,0,0,190.25714285714287,961.57757966873419,FASN,Gluconeogenesis,wikipathways
VEGFA-VEGFR2 Signaling Pathway WP3888,2/432,1.1957001848216733E-2,1.899053234716775E-2,0,0,15.164341085271317,67.124019316910207,ACACB;ACACA,Gluconeogenesis,wikipathways
Metabolic reprogramming in colon cancer WP4290,1/42,1.6679797556906864E-2,2.4645038852455978E-2,0,0,69.515679442508713,284.56639751252425,FASN,Gluconeogenesis,wikipathways
Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,1/44,1.746796731842876E-2,2.4645038852455978E-2,0,0,66.275747508305642,268.2435666902731,ACACA,Gluconeogenesis,wikipathways
Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,1/46,1.8255584335152574E-2,2.4645038852455978E-2,0,0,63.323809523809523,253.50320962011816,FASN,Gluconeogenesis,wikipathways
Corticotropin-releasing hormone signaling pathway WP2355,1/93,3.6606264956983832E-2,4.7065197801836357E-2,0,0,30.900621118012424,102.2049130477516,ACACA,Gluconeogenesis,wikipathways
Angiopoietin Like Protein 8 Regulatory Pathway WP3915,1/132,5.1604870488467222E-2,6.1904438831541259E-2,0,0,21.658669574700109,64.199311974858205,FASN,Gluconeogenesis,wikipathways
Endoderm differentiation WP2853,1/141,5.5036928219595174E-2,6.1904438831541259E-2,0,0,20.257142857142856,58.740668168190489,ACACA,Gluconeogenesis,wikipathways
Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,1/144,5.6178529985824038E-2,6.1904438831541259E-2,0,0,19.829170829170828,57.092557604123598,ACACB,Gluconeogenesis,wikipathways
Mesodermal commitment pathway WP2857,1/147,5.7318924844019681E-2,6.1904438831541259E-2,0,0,19.418786692759294,55.520727497935795,ACACA,Gluconeogenesis,wikipathways
Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,1/303,0.1149831829216247,0.11940561303399488,0,0,9.3140964995269631,20.146105687099649,ACACA,Gluconeogenesis,wikipathways
Nuclear Receptors Meta-Pathway WP2882,1/319,0.1207191050086845,0.1207191050086845,0,0,8.8382749326145547,18.686666393634923,FASN,Gluconeogenesis,wikipathways
Fatty acid beta-oxidation WP143,8/34,2.8599320165720318E-23,6.005857234801267E-22,0,0,159728,8291266.3302334575,CPT1A;ACADVL;ECHS1;CPT2;ACADL;ACSL1;ACSL3;ACADS,Gluconeogenesis,wikipathways
Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,7/17,6.1229028057808718E-22,6.4290479460699157E-21,0,0,13987.4,683212.25552935491,CPT1A;ACADVL;CPT2;ACADL;ACSL1;ACSL3;ACADS,Gluconeogenesis,wikipathways
PPAR signaling pathway WP3942,5/67,2.0128490551944196E-11,1.4089943386360936E-10,0,0,535.75268817204301,13194.991272615236,CPT1A;CPT2;ACADL;ACSL1;ACSL3,Gluconeogenesis,wikipathways
Thermogenesis WP4321,4/108,5.534919061773268E-8,2.7069464710162031E-7,0,0,191.23076923076923,3195.390388384536,CPT1A;CPT2;ACSL1;ACSL3,Gluconeogenesis,wikipathways
Fatty Acid Biosynthesis WP357,3/22,6.4451106452766731E-8,2.7069464710162031E-7,0,0,630.72631578947369,10443.162003489322,ECHS1;ACSL1;ACSL3,Gluconeogenesis,wikipathways
Omega-3/Omega-6 FA synthesis WP4723,2/14,1.270931618352025E-5,3.8127948550560753E-5,0,0,555,6256.6122779936395,ACSL1;ACSL3,Gluconeogenesis,wikipathways
Omega-9 FA synthesis WP4724,2/14,1.270931618352025E-5,3.8127948550560753E-5,0,0,555,6256.6122779936395,ACSL1;ACSL3,Gluconeogenesis,wikipathways
Fatty acid transporters WP5061,2/18,2.1351432280008236E-5,5.6047509735021622E-5,0,0,416.16666666666669,4475.619360309719,ACSL1;ACSL3,Gluconeogenesis,wikipathways
PPAR-alpha pathway WP2878,2/26,4.5282143274541853E-5,1.0565833430726432E-4,0,0,277.33333333333331,2774.0537874782267,CPT1A;CPT2,Gluconeogenesis,wikipathways
Ferroptosis WP4313,2/40,1.0837395249617636E-4,2.2758530024197038E-4,0,0,175.03508771929825,1598.0568361483106,ACSL1;ACSL3,Gluconeogenesis,wikipathways
Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,2/46,1.4363165889914778E-4,2.7420589426200941E-4,0,0,151.12121212121212,1337.159543603372,ACSL1;ACSL3,Gluconeogenesis,wikipathways
Ciliary landscape WP4352,2/216,3.1145036099737853E-3,5.1628202638811472E-3,0,0,30.806853582554517,177.80746994389892,ECHS1;ACSL3,Gluconeogenesis,wikipathways
Ketogenesis and Ketolysis WP4742,1/8,3.1960315919264243E-3,5.1628202638811472E-3,0,0,407.85714285714283,2343.4840743955892,CPT2,Gluconeogenesis,wikipathways
Leptin and adiponectin WP3934,1/10,3.9936462613403625E-3,5.9904693920105438E-3,0,0,317.1904761904762,1751.8590547314027,CPT1A,Gluconeogenesis,wikipathways
IL-18 signaling pathway WP4754,2/272,4.8882840152581755E-3,6.8435976213614448E-3,0,0,24.348148148148148,129.55440124056366,CPT1A;ACADS,Gluconeogenesis,wikipathways
Nuclear Receptors Meta-Pathway WP2882,2/319,6.664061415446774E-3,8.7465806077738906E-3,0,0,20.68874868559411,103.671860843041,CPT1A;CPT2,Gluconeogenesis,wikipathways
Tryptophan metabolism WP465,1/42,1.6679797556906864E-2,2.0604455805590834E-2,0,0,69.515679442508713,284.56639751252425,ECHS1,Gluconeogenesis,wikipathways
AMP-activated protein kinase (AMPK) signaling WP1403,1/69,2.7273557473830964E-2,3.1819150386136127E-2,0,0,41.857142857142854,150.7626325151401,CPT1A,Gluconeogenesis,wikipathways
Fragile X Syndrome  WP4549,1/121,4.7395325572656036E-2,5.2384307211882995E-2,0,0,23.657142857142858,72.13610926322491,CPT1A,Gluconeogenesis,wikipathways
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,1/158,6.1490064457543681E-2,6.4564567680420862E-2,0,0,18.048225659690626,50.334329635540946,CPT1A,Gluconeogenesis,wikipathways
Circadian rhythm related genes WP3594,1/201,7.7640891627719144E-2,7.7640891627719144E-2,0,0,14.137142857142857,36.129745169116553,CPT1A,Gluconeogenesis,wikipathways
Synthesis and Degradation of Ketone Bodies WP311,2/5,7.4966635810394549E-7,1.2744328087767073E-5,0,0,3331.8333333333335,46990.969827806068,BDH1;HMGCS2,Gluconeogenesis,wikipathways
Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,2/46,7.7171196243681905E-5,6.559551680712962E-4,0,0,226.70454545454547,2146.7751285263748,HMGCS1;HMGCS2,Gluconeogenesis,wikipathways
PPAR signaling pathway WP3942,2/67,1.6439509275837475E-4,9.3157219229745702E-4,0,0,153.30000000000001,1335.7393739315212,HMGCS2;ACAA1,Gluconeogenesis,wikipathways
Amino Acid metabolism WP3925,2/91,3.0350366026081743E-4,1.2898905561084741E-3,0,0,111.82584269662921,905.80239687134815,HMGCS2;ACAA1,Gluconeogenesis,wikipathways
Mevalonate pathway WP3963,1/7,2.0983872819732461E-3,6.7939337461452838E-3,0,0,666.26666666666665,4108.5908256912071,HMGCS1,Gluconeogenesis,wikipathways
Ketogenesis and Ketolysis WP4742,1/8,2.3978589692277472E-3,6.7939337461452838E-3,0,0,571.05714285714282,3445.2899826083253,BDH1,Gluconeogenesis,wikipathways
Mevalonate arm of cholesterol biosynthesis pathway WP4190,1/11,3.2958256764104633E-3,8.0041480712825536E-3,0,0,399.68,2284.2105915703851,HMGCS1,Gluconeogenesis,wikipathways
Cholesterol Biosynthesis Pathway WP197,1/15,4.4920683932145331E-3,9.0495576305825078E-3,0,0,285.42857142857144,1542.8675927558304,HMGCS1,Gluconeogenesis,wikipathways
SREBF and miR33 in cholesterol and lipid homeostasis WP2011,1/16,4.7909422750142686E-3,9.0495576305825078E-3,0,0,266.38666666666666,1422.7786907214238,HMGCS1,Gluconeogenesis,wikipathways
Fatty Acid Biosynthesis WP357,1/22,6.5826171479286674E-3,1.1190449151478734E-2,0,0,190.21904761904761,955.5316921910462,ACAA2,Gluconeogenesis,wikipathways
PPAR-alpha pathway WP2878,1/26,7.7755741446350474E-3,1.172651856675966E-2,0,0,159.75200000000001,775.87839812914592,ACAA1,Gluconeogenesis,wikipathways
Eicosanoid metabolism via lipooxygenases (LOX) WP4721,1/29,8.669508668721345E-3,1.172651856675966E-2,0,0,142.61428571428573,677.12452238539186,ACAA1,Gluconeogenesis,wikipathways
Eicosanoid metabolism via cyclooxygenases (COX) WP4719,1/30,8.9673377275220935E-3,1.172651856675966E-2,0,0,137.68965517241378,649.09195214683928,ACAA1,Gluconeogenesis,wikipathways
Endochondral Ossification with Skeletal Dysplasias WP4808,1/64,1.9049268540735301E-2,2.1589171012833343E-2,0,0,63.273015873015872,250.60711544601855,HMGCS1,Gluconeogenesis,wikipathways
Endochondral Ossification WP474,1/64,1.9049268540735301E-2,2.1589171012833343E-2,0,0,63.273015873015872,250.60711544601855,HMGCS1,Gluconeogenesis,wikipathways
Sterol regulatory element-binding proteins (SREBP) signaling WP1982,1/69,2.0524671815930529E-2,2.1807463804426188E-2,0,0,58.60588235294118,227.74993771071073,HMGCS1,Gluconeogenesis,wikipathways
Nuclear Receptors Meta-Pathway WP2882,1/319,9.1974887240547809E-2,9.1974887240547809E-2,0,0,12.374842767295597,29.52934114172427,ACAA1,Gluconeogenesis,wikipathways
Urea cycle and metabolism of amino groups WP497,3/21,1.9909621968197241E-8,1.990962196819724E-7,0,0,1109.7777777777778,19678.64914537227,OAT;CKM;CKB,Gluconeogenesis,wikipathways
Urea cycle and associated pathways WP4595,2/24,2.063922922489771E-5,1.0319614612448855E-4,0,0,453.90909090909093,4896.9151445711996,OAT;GOT2,Gluconeogenesis,wikipathways
Amino Acid metabolism WP3925,2/91,3.0350366026081743E-4,1.0116788675360582E-3,0,0,111.82584269662921,905.80239687134815,OAT;GOT2,Gluconeogenesis,wikipathways
Alanine and aspartate metabolism WP106,1/12,3.5949984464796287E-3,8.9841367864290662E-3,0,0,363.32727272727271,2044.8828145385057,GOT2,Gluconeogenesis,wikipathways
Biomarkers for pyrimidine metabolism disorders WP4584,1/15,4.4920683932145331E-3,8.9841367864290662E-3,0,0,285.42857142857144,1542.8675927558304,CKB,Gluconeogenesis,wikipathways
"NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046",1/24,7.1792448741713026E-3,1.1965408123618838E-2,0,0,173.66086956521738,857.28748845676546,GOT2,Gluconeogenesis,wikipathways
Metabolic reprogramming in colon cancer WP4290,1/42,1.2535476566438152E-2,1.5906142838158565E-2,0,0,97.331707317073167,426.23428554035564,GOT2,Gluconeogenesis,wikipathways
Glycolysis and Gluconeogenesis WP534,1/45,1.3425837026561787E-2,1.5906142838158565E-2,0,0,90.681818181818187,390.89071422300736,GOT2,Gluconeogenesis,wikipathways
Exercise-induced Circadian Regulation WP410,1/48,1.4315528554342706E-2,1.5906142838158565E-2,0,0,84.88085106382978,360.43893024633047,AZIN1,Gluconeogenesis,wikipathways
22q11.2 copy number variation syndrome WP4657,1/131,3.8666599358262888E-2,3.8666599358262888E-2,0,0,30.56,99.404929824076106,OAT,Gluconeogenesis,wikipathways
Glycogen Synthesis and Degradation WP500,10/40,1.9783128713231637E-26,1.5430840396320676E-24,0,0,3326.3333333333335,196868.93196238243,GYS2;GSK3B;GYS1;HK3;GSK3A;UGP2;GBE1;HK2;PGM1;HK1,Gluconeogenesis,wikipathways
Glucuronidation WP698,5/26,1.9420246519625378E-12,7.5738961426538969E-11,0,0,679.14965986394554,18314.825866288204,UGP2;PGM2;PGM5;PGM1;HK1,Gluconeogenesis,wikipathways
Pathways in clear cell renal cell carcinoma WP4018,5/85,9.51977109616949E-10,2.4751404850040673E-8,0,0,177.75,3692.3083423869493,HK3;PGM2;HK2;PGM1;HK1,Gluconeogenesis,wikipathways
Insulin Signaling WP481,4/160,1.8574514579113422E-6,3.601311759954645E-5,0,0,63.564102564102562,838.81129680069841,GYS2;GSK3B;GYS1;GSK3A,Gluconeogenesis,wikipathways
Glycolysis and Gluconeogenesis WP534,3/45,2.3085331794581057E-6,3.601311759954645E-5,0,0,158.30158730158729,2054.5801900265933,HK3;HK2;HK1,Gluconeogenesis,wikipathways
Angiopoietin Like Protein 8 Regulatory Pathway WP3915,3/132,5.9187674114198749E-5,7.3830794776036433E-4,0,0,51.315245478036175,499.54351032060424,GSK3B;GYS1;GSK3A,Gluconeogenesis,wikipathways
PI3K/AKT/mTOR - VitD3 signaling WP4141,2/22,7.5723892077986086E-5,7.3830794776036433E-4,0,0,199.68,1894.6470730177257,GSK3B;HK3,Gluconeogenesis,wikipathways
Regulation of apoptosis by parathyroid hormone-related protein WP3872,2/22,7.5723892077986086E-5,7.3830794776036433E-4,0,0,199.68,1894.6470730177257,GSK3B;GSK3A,Gluconeogenesis,wikipathways
T-Cell Receptor and Co-stimulatory Signaling WP2583,2/29,1.3278088986713745E-4,1.1507677121818578E-3,0,0,147.85925925925926,1319.9115485815607,GSK3B;GSK3A,Gluconeogenesis,wikipathways
IL-5 signaling pathway WP127,2/40,2.5416386531107297E-4,1.982478149426369E-3,0,0,105,869.14079279354064,GSK3B;GSK3A,Gluconeogenesis,wikipathways
Wnt Signaling Pathway WP363,2/52,4.3035527752799174E-4,3.0516101497439414E-3,0,0,79.751999999999995,618.14973402141493,GSK3B;GSK3A,Gluconeogenesis,wikipathways
Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,3/303,6.8438880460281002E-4,4.4485272299182648E-3,0,0,21.875555555555554,159.40683150707721,GYS2;GSK3B;GYS1,Gluconeogenesis,wikipathways
AMP-activated protein kinase (AMPK) signaling WP1403,2/69,7.570983460178036E-4,4.5425900761068214E-3,0,0,59.465671641791047,427.32135097109114,GYS2;GYS1,Gluconeogenesis,wikipathways
Leptin signaling pathway WP2034,2/76,9.176063110616548E-4,4.9708664731752689E-3,0,0,53.821621621621624,376.4145417994182,GSK3B;GSK3A,Gluconeogenesis,wikipathways
PI3K-Akt signaling pathway WP4172,3/340,9.5593586022601324E-4,4.9708664731752689E-3,0,0,19.437190900098912,135.14328456048005,GYS2;GSK3B;GYS1,Gluconeogenesis,wikipathways
B Cell Receptor Signaling Pathway WP23,2/97,1.4886277004994327E-3,7.2570600399347344E-3,0,0,41.88,272.63463670031967,GSK3B;GSK3A,Gluconeogenesis,wikipathways
Nonalcoholic fatty liver disease WP4396,2/155,3.742863591746855E-3,1.7173138832720862E-2,0,0,25.928104575163399,144.88376689825418,GSK3B;GSK3A,Gluconeogenesis,wikipathways
Glycolysis in senescence WP5049,1/11,6.5817961978748346E-3,2.8521116857457614E-2,0,0,181.61818181818182,912.34941820810161,HK1,Gluconeogenesis,wikipathways
Computational Model of Aerobic Glycolysis WP4629,1/12,7.1781707148818458E-3,2.946827977688337E-2,0,0,165.099173553719,815.04685721649503,HK1,Gluconeogenesis,wikipathways
MAP3K1 role in promoting and blocking gonadal determination WP4872,1/17,1.0155125895608219E-2,3.6004537266247319E-2,0,0,113.47727272727273,520.83534082548363,GSK3B,Gluconeogenesis,wikipathways
Cori Cycle WP1946,1/17,1.0155125895608219E-2,3.6004537266247319E-2,0,0,113.47727272727273,520.83534082548363,HK1,Gluconeogenesis,wikipathways
Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,1/17,1.0155125895608219E-2,3.6004537266247319E-2,0,0,113.47727272727273,520.83534082548363,GSK3B,Gluconeogenesis,wikipathways
NRF2-ARE regulation WP4357,1/23,1.3716673976595E-2,4.6517416094539563E-2,0,0,82.504132231404952,353.87203010919802,GSK3B,Gluconeogenesis,wikipathways
IL-7 signaling pathway WP205,1/25,1.4901244370148439E-2,4.833828627675326E-2,0,0,75.621212121212125,318.08630270790064,GSK3B,Gluconeogenesis,wikipathways
Wnt/beta-catenin signaling pathway in leukemia WP3658,1/26,1.5493040473318351E-2,4.833828627675326E-2,0,0,72.592727272727274,302.52034425805169,GSK3B,Gluconeogenesis,wikipathways
PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,1/30,1.7856968008938604E-2,5.3570904026815816E-2,0,0,62.567398119122259,251.85639443535081,GSK3B,Gluconeogenesis,wikipathways
IL17 signaling pathway WP2112,1/32,1.9036979887302796E-2,5.3579484269681787E-2,0,0,58.524926686217007,231.83899894541258,GSK3B,Gluconeogenesis,wikipathways
miRNA regulation of prostate cancer signaling pathways WP3981,1/33,1.962649841488355E-2,5.3579484269681787E-2,0,0,56.69318181818182,222.85379213708367,GSK3B,Gluconeogenesis,wikipathways
The influence of laminopathies on Wnt signaling WP4844,1/35,2.0804561456238449E-2,5.3579484269681787E-2,0,0,53.352941176470587,206.61369382894844,GSK3B,Gluconeogenesis,wikipathways
Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,1/37,2.1981326879869451E-2,5.3579484269681787E-2,0,0,50.383838383838381,192.34342502593887,GSK3B,Gluconeogenesis,wikipathways
Photodynamic therapy-induced HIF-1 survival signaling WP3614,1/37,2.1981326879869451E-2,5.3579484269681787E-2,0,0,50.383838383838381,192.34342502593887,HK1,Gluconeogenesis,wikipathways
Melatonin metabolism and effects WP3298,1/37,2.1981326879869451E-2,5.3579484269681787E-2,0,0,50.383838383838381,192.34342502593887,GSK3B,Gluconeogenesis,wikipathways
TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,1/42,2.4917571797868982E-2,5.683715211133486E-2,0,0,44.228381374722836,163.29923491461832,GSK3B,Gluconeogenesis,wikipathways
Metabolic reprogramming in colon cancer WP4290,1/42,2.4917571797868982E-2,5.683715211133486E-2,0,0,44.228381374722836,163.29923491461832,HK3,Gluconeogenesis,wikipathways
IL-6 signaling pathway WP364,1/43,2.5503850306368207E-2,5.683715211133486E-2,0,0,43.17316017316017,158.39912320457492,GSK3B,Gluconeogenesis,wikipathways
Regulation of Microtubule Cytoskeleton WP2038,1/46,2.7260747763880669E-2,5.8357135383794202E-2,0,0,40.288888888888891,145.1329634798573,GSK3B,Gluconeogenesis,wikipathways
Energy Metabolism WP1541,1/47,2.7845734763739902E-2,5.8357135383794202E-2,0,0,39.411067193675891,141.13400615713857,GSK3B,Gluconeogenesis,wikipathways
Exercise-induced Circadian Regulation WP410,1/48,2.8430399289540761E-2,5.8357135383794202E-2,0,0,38.570599613152808,137.3227634294791,UGP2,Gluconeogenesis,wikipathways
Synaptic signaling pathways associated with autism spectrum disorder WP4539,1/50,2.9598761568907096E-2,5.8978947597593132E-2,0,0,36.99257884972171,130.21471940651389,GSK3B,Gluconeogenesis,wikipathways
Copper homeostasis WP3286,1/52,3.0765835877853052E-2,5.8978947597593132E-2,0,0,35.538324420677363,123.7213609818225,GSK3B,Gluconeogenesis,wikipathways
Cardiac Progenitor Differentiation WP2406,1/53,3.1348890445829294E-2,5.8978947597593132E-2,0,0,34.853146853146853,120.68168393395273,GSK3B,Gluconeogenesis,wikipathways
The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,1/55,3.2514035214057754E-2,5.8978947597593132E-2,0,0,33.558922558922561,114.97566851206538,GSK3B,Gluconeogenesis,wikipathways
Cardiac Hypertrophic Response WP2795,1/55,3.2514035214057754E-2,5.8978947597593132E-2,0,0,33.558922558922561,114.97566851206538,GSK3B,Gluconeogenesis,wikipathways
Notch Signaling Pathway Netpath WP61,1/61,3.6001766128656791E-2,6.3013452324984093E-2,0,0,30.193939393939395,100.37030934492944,GSK3B,Gluconeogenesis,wikipathways
T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,1/62,3.6581932884295822E-2,6.3013452324984093E-2,0,0,29.697466467958272,98.245182252874329,GSK3B,Gluconeogenesis,wikipathways
Endometrial cancer WP4155,1/63,3.7161779576272667E-2,6.3013452324984093E-2,0,0,29.217008797653961,96.196255749374828,GSK3B,Gluconeogenesis,wikipathways
Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,1/66,3.8899400851019943E-2,6.455645247616075E-2,0,0,27.864335664335666,90.469268293855038,GSK3B,Gluconeogenesis,wikipathways
Sterol regulatory element-binding proteins (SREBP) signaling WP1982,1/69,4.0634147279785517E-2,6.6030489329651471E-2,0,0,26.63101604278075,85.303045825353649,GSK3A,Gluconeogenesis,wikipathways
Chromosomal and microsatellite instability in colorectal cancer  WP4216,1/73,4.2942678013426154E-2,6.8357732347902864E-2,0,0,25.146464646464647,79.15828251915687,GSK3B,Gluconeogenesis,wikipathways
Prolactin Signaling Pathway WP2037,1/76,4.4670733264737819E-2,6.9686343892990998E-2,0,0,24.136969696969697,75.02824312324114,GSK3B,Gluconeogenesis,wikipathways
Alzheimer's disease WP2059,1/83,4.8691745544066009E-2,7.1490946202724517E-2,0,0,22.068736141906875,66.697144217431187,GSK3B,Gluconeogenesis,wikipathways
EGFR Tyrosine Kinase Inhibitor Resistance WP4806,1/84,4.9264907729901206E-2,7.1490946202724517E-2,0,0,21.801752464403066,65.635118984630409,GSK3B,Gluconeogenesis,wikipathways
MicroRNAs in cardiomyocyte hypertrophy WP1544,1/84,4.9264907729901206E-2,7.1490946202724517E-2,0,0,21.801752464403066,65.635118984630409,GSK3B,Gluconeogenesis,wikipathways
Acute viral myocarditis WP4298,1/86,5.0410282578844209E-2,7.1490946202724517E-2,0,0,21.286631016042779,63.595089599609956,GSK3B,Gluconeogenesis,wikipathways
ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,1/86,5.0410282578844209E-2,7.1490946202724517E-2,0,0,21.286631016042779,63.595089599609956,GSK3B,Gluconeogenesis,wikipathways
Androgen receptor signaling pathway WP138,1/90,5.2697238674974604E-2,7.2213483970861844E-2,0,0,20.325842696629213,59.822862127609227,GSK3B,Gluconeogenesis,wikipathways
ErbB signaling pathway WP673,1/91,5.3268188288120896E-2,7.2213483970861844E-2,0,0,20.098989898989899,58.938598932853118,GSK3B,Gluconeogenesis,wikipathways
Corticotropin-releasing hormone signaling pathway WP2355,1/93,5.440914131550411E-2,7.2213483970861844E-2,0,0,19.660079051383399,57.234876289079708,GSK3B,Gluconeogenesis,wikipathways
LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,1/94,5.4979145063769622E-2,7.2213483970861844E-2,0,0,19.44770283479961,56.41392256593172,GSK3B,Gluconeogenesis,wikipathways
Thyroid hormones production and their peripheral downstream signaling effects WP4746,1/95,5.5548833823739881E-2,7.2213483970861844E-2,0,0,19.239845261121857,55.612633361315446,GSK3B,Gluconeogenesis,wikipathways
Neural Crest Differentiation WP2064,1/101,5.8960360820228652E-2,7.4889874799789341E-2,0,0,18.079999999999998,51.182489597636589,GSK3B,Gluconeogenesis,wikipathways
Wnt signaling pathway and pluripotency WP399,1/102,5.9527849199832554E-2,7.4889874799789341E-2,0,0,17.900090009000902,50.501721239958272,GSK3B,Gluconeogenesis,wikipathways
Senescence and Autophagy in Cancer WP615,1/105,6.122843268090386E-2,7.5806630938261926E-2,0,0,17.38111888111888,48.547961155895422,GSK3B,Gluconeogenesis,wikipathways
DNA damage response (only ATM dependent) WP710,1/110,6.4056475811433547E-2,7.8068829895184641E-2,0,0,16.579649708090074,45.560714091353951,GSK3B,Gluconeogenesis,wikipathways
Gastrin signaling pathway WP4659,1/114,6.6313285228921021E-2,7.8512027340689322E-2,0,0,15.989541432019308,43.38546242886158,GSK3B,Gluconeogenesis,wikipathways
Wnt signaling WP428,1/115,6.6876707624933057E-2,7.8512027340689322E-2,0,0,15.848484848484848,42.868638611078062,GSK3B,Gluconeogenesis,wikipathways
ESC Pluripotency Pathways WP3931,1/116,6.7439818356745951E-2,7.8512027340689322E-2,0,0,15.709881422924902,42.362004092723232,GSK3B,Gluconeogenesis,wikipathways
Cell cycle WP179,1/120,6.968914773080194E-2,7.9937551808861043E-2,0,0,15.178762414056532,40.431831445855714,GSK3B,Gluconeogenesis,wikipathways
Ectoderm Differentiation WP2858,1/138,7.9749718693422039E-2,9.0151855914303164E-2,0,0,13.172528201725282,33.311506865252262,PGM1,Gluconeogenesis,wikipathways
Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,1/144,8.308101560487012E-2,9.2575988816855276E-2,0,0,12.616020343293071,31.387889738679515,GSK3B,Gluconeogenesis,wikipathways
Integrated breast cancer pathway WP1984,1/152,8.750554999553678E-2,9.5992673101808756E-2,0,0,11.94280553883203,29.093307967223456,GSK3A,Gluconeogenesis,wikipathways
Breast cancer pathway WP4262,1/154,8.8608621324746548E-2,9.5992673101808756E-2,0,0,11.785502079619727,28.562472126761907,GSK3B,Gluconeogenesis,wikipathways
Epithelial to mesenchymal transition in colorectal cancer WP4239,1/160,9.1910505584944999E-2,9.8205745693502877E-2,0,0,11.337335620354489,27.061539213996053,GSK3B,Gluconeogenesis,wikipathways
Chemokine signaling pathway WP3929,1/164,9.4105665950910758E-2,9.9192458705014031E-2,0,0,11.056887897378695,26.13115251802758,GSK3B,Gluconeogenesis,wikipathways
Focal Adhesion WP306,1/198,0.11256908393690102,0.11707184729437706,0,0,9.1329026303645602,19.947977849834988,GSK3B,Gluconeogenesis,wikipathways
Circadian rhythm related genes WP3594,1/201,0.11418153310963532,0.11718631029673099,0,0,8.9945454545454542,19.517855136107741,GSK3B,Gluconeogenesis,wikipathways
IL-18 signaling pathway WP4754,1/272,0.15156771036528016,0.15353612218820586,0,0,6.6142234149614225,12.47920625870152,GSK3B,Gluconeogenesis,wikipathways
VEGFA-VEGFR2 Signaling Pathway WP3888,1/432,0.23057564766560595,0.23057564766560595,0,0,4.1250790972368696,6.0522182085051508,GSK3B,Gluconeogenesis,wikipathways
Glycogen Synthesis and Degradation WP500,4/40,1.7150492788048153E-9,2.0580591345657784E-8,0,0,443.44444444444446,8950.4046305302963,PYGB;PYGM;PYGL;PGM1,Gluconeogenesis,wikipathways
Glucuronidation WP698,3/26,1.6295949721380597E-7,9.7775698328283584E-7,0,0,434.08695652173913,6784.6767511856724,PGM2;PGM5;PGM1,Gluconeogenesis,wikipathways
PI3K-Akt signaling pathway WP4172,3/340,3.7910484895495295E-4,1.5164193958198118E-3,0,0,29.160237388724035,229.71553631563273,G6PC2;G6PC;G6PC3,Gluconeogenesis,wikipathways
Pathways in clear cell renal cell carcinoma WP4018,2/85,6.3028283688298904E-4,1.8908485106489672E-3,0,0,68.53012048192771,505.02188772388456,PGM2;PGM1,Gluconeogenesis,wikipathways
Glycolysis and Gluconeogenesis WP534,1/45,2.0072530463390581E-2,4.8174073112137394E-2,0,0,56.667613636363633,221.47987353276542,G6PC,Gluconeogenesis,wikipathways
Amino Acid metabolism WP3925,1/91,4.0220252479191559E-2,6.9692787969826281E-2,0,0,27.640277777777779,88.818843426343989,G6PC2,Gluconeogenesis,wikipathways
TNF-alpha signaling pathway WP231,1/92,4.0654126315732002E-2,6.9692787969826281E-2,0,0,27.335164835164836,87.545100688435838,PYGL,Gluconeogenesis,wikipathways
DNA damage response (only ATM dependent) WP710,1/110,4.843410188094173E-2,7.2509816041474828E-2,0,0,22.800458715596331,69.029554527160585,G6PC,Gluconeogenesis,wikipathways
Angiopoietin Like Protein 8 Regulatory Pathway WP3915,1/132,5.7866768719600295E-2,7.2509816041474828E-2,0,0,18.950381679389313,54.00123507299854,G6PC,Gluconeogenesis,wikipathways
Ectoderm Differentiation WP2858,1/138,6.0424846701229031E-2,7.2509816041474828E-2,0,0,18.114963503649633,50.837016399857454,PGM1,Gluconeogenesis,wikipathways
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,1/158,6.8907244430395656E-2,7.5171539378613442E-2,0,0,15.79140127388535,42.241903064880837,G6PC,Gluconeogenesis,wikipathways
IL-18 signaling pathway WP4754,1/272,0.11597009421931868,0.11597009421931868,0,0,9.0959409594095941,19.596503768950914,PYGB,Gluconeogenesis,wikipathways
Urea cycle and metabolism of amino groups WP497,6/21,1.7071852291583021E-17,1.8779037520741325E-16,0,0,3995.4,154258.80066292384,ARG2;CPS1;ARG1;ASL;ASS1;OTC,Gluconeogenesis,wikipathways
Urea cycle and related diseases WP4571,5/9,2.6443767289423328E-16,1.454407200918283E-15,0,0,8328.3333333333339,298728.37279949087,CPS1;ARG1;ASL;ASS1;OTC,Gluconeogenesis,wikipathways
Urea cycle and associated pathways WP4595,5/24,8.9052696416974548E-14,3.2652655352890668E-13,0,0,1752.0175438596491,52647.335466459233,CPS1;ARG1;ASL;ASS1;OTC,Gluconeogenesis,wikipathways
Amino Acid metabolism WP3925,6/91,2.0851177642491309E-13,5.7340738516851105E-13,0,0,702.6,20515.063441800212,ARG2;CPS1;ARG1;CAD;ASS1;OTC,Gluconeogenesis,wikipathways
Biomarkers for urea cycle disorders WP4583,4/12,5.1907345292919795E-12,1.1419615964442356E-11,0,0,2498,64908.396460605429,ARG1;ASL;ASS1;OTC,Gluconeogenesis,wikipathways
Pyrimidine metabolism and related diseases WP4225,3/17,2.8485265782063636E-8,5.2222987267116667E-8,0,0,856.2,14875.515091456709,CPS1;CAD;OTC,Gluconeogenesis,wikipathways
Alanine and aspartate metabolism WP106,2/12,9.2214027460096553E-6,1.4490775743729458E-5,0,0,666.06666666666672,7722.3658701781433,ASL;ASS1,Gluconeogenesis,wikipathways
Endothelin Pathways WP2197,1/33,1.3126184702817524E-2,1.8048503966374096E-2,0,0,89.107142857142861,386.1142784895618,CAD,Gluconeogenesis,wikipathways
Pyrimidine metabolism WP4022,1/85,3.3504105816256062E-2,4.0949462664312965E-2,0,0,33.857142857142854,114.98181239681574,CAD,Gluconeogenesis,wikipathways
Spinal Cord Injury WP2431,1/118,4.6244434404317553E-2,5.0868877844749312E-2,0,0,24.267399267399266,74.593475481613424,ARG1,Gluconeogenesis,wikipathways
IL-18 signaling pathway WP4754,1/272,0.10377659812326195,0.10377659812326195,0,0,10.395888244596732,23.552038524197574,ARG1,Gluconeogenesis,wikipathways
